文献速递中医内科中药与中成药合理使用

达原饮挥发性成分在新冠肺炎防治中的重要作用

The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic.
PubMed 文献 · Front Pharmacol · 2020-09-25

本文综述芳香中药在瘟疫防治中的应用,重点讨论达原饮挥发性成分对COVID-19的防治作用及可能机制。2003年SARS期间112例确诊患者使用达原饮,超过93.7%症状明显缓解并康复,达原饮被选为国家推荐的新冠肺炎处方之一。

要点

  • 达原饮被列入国家新冠肺炎诊疗方案推荐处方。
  • 2003年SARS期间112例使用达原饮,超93.7%症状明显缓解并康复。
  • 芳香中药可通过外熏、艾灸、佩戴香囊等方式用于防疫。

核心结论

  • 芳香中药在疫病防治中具有独特优势,达原饮挥发性成分对COVID-19防治可能发挥重要作用。

研究设计与样本

  • 本文为综述,基于国家新冠肺炎诊疗方案(试行第七版)推荐及达原饮既往SARS治疗经验进行讨论。
  • 2003年1月至4月,112例确诊SARS患者使用达原饮治疗。

主要发现

  • 2003年1月至4月112例确诊SARS患者使用达原饮,超过93.7%的患者症状明显缓解并康复。
  • 达原饮被选为国家推荐的新冠肺炎处方之一。
  • 芳香中药的独特性质、化学成分及作用机制值得广泛深入的实验与临床研究。

关键数值与推荐

  • 国家新冠肺炎诊疗方案(试行第七版)在医学观察期、临床治疗期和恢复期选用富含芳香中药的中成药或处方。
  • 部分地方卫健委或中医药管理局推荐外熏、艾灸、佩戴香囊等芳香中药使用方式。

临床怎么用

  • 在医学观察期、临床治疗期和恢复期可选用富含芳香中药的中成药或处方。
  • 可结合外熏、艾灸、佩戴香囊等芳香中药外用方式用于防疫。

局限性

  • 本文为综述,未报告针对COVID-19的原始临床试验数据。
  • 达原饮挥发性成分防治COVID-19的作用机制为推测,尚需实验与临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aromatic Chinese herbs have been used to prevent plagues since ancient times. Traditional Chinese medicine has unique advantages in the prevention and treatment of epidemic diseases. According to the traditional Chinese medicine treatment plan in the National COVID-19 Diagnosis and Treatment Plan (Trial Seventh Edition) of the National Health Commission, Chinese patent medicines or prescriptions rich in aromatic Chinese herbs are selected for prevention and treatment during the period of medical observation, clinical treatment, and recovery of confirmed COVID-19 patients. Some local health committees or traditional Chinese medicine administrations recommend a variety of other ways of using traditional aromatic Chinese herbs to prevent and cure COVID-19. These involve external fumigation, use of moxibustion, and wearing of sachet. The efficacy of aromatic Chinese herbs plays a decisive role in the prevention and treatment of COVID-19. The unique properties, chemical composition, and mechanism of action of aromatic Chinese herbs are worthy of extensive and in-depth experimental and clinical research. The findings are expected to provide a reference for follow-up treatment of novel coronavirus and the development of corresponding drugs. In 2003, Dayuan-Yin produced excellent results in the treatment of the SARS virus. Individually, 112 confirmed cases were administered this drug between January and April 2003, and more than 93.7% of the patients showed noticeable mitigation of the symptoms, as well as recovery. Dayuan-Yin also was selected as one of the nationally recommended prescriptions for the COVID-19. Based on the national recommendation of Dayuan-Yin prescription, this review discusses the role of volatile components in the prevention and treatment of COVID-19, and speculates the possible mechanism of action, so as to provide a basis for the prevention and treatment of COVID-19.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Zhang XR, Li TN, Ren YY, et al. The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic. Front Pharmacol. 2020. PMID: 33101037. doi:10.3389/fphar.2020.583651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。